Letter by Cheen Regarding Article, “Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States”
Author(s) -
McVin Hua Heng Cheen
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.038646
Subject(s) - apixaban , medicine , atrial fibrillation , kidney disease , intensive care medicine , stroke (engine) , end stage renal disease , randomized controlled trial , cardiology , disease , warfarin , rivaroxaban , mechanical engineering , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom